| Literature DB >> 34894605 |
Younes Adam Tabi1, Maria Raquel Maio2, Bahaaeddin Attaallah2, Shannon Dickson3, Daniel Drew3, Mohamad Imran Idris2, Annika Kienast3, Verena Klar3, Lisa Nobis4, Olivia Plant3, Youssuf Saleh2, Timothy Ravinder Sandhu5, Ellie Slavkova3, Sofia Toniolo2, Nahid Zokaei3, Sanjay G Manohar6, Masud Husain7.
Abstract
Mechanisms underlying visual imagery, the ability to create vivid mental representations of a scene in the absence of sensory input, remain to be fully understood. Some previous studies have proposed that visual imagery might be related to visual short-term memory (STM), with a common mechanism involving retention of visual information over short periods of time. Other observations have shown a strong relationship between visual imagery and functional activity in the hippocampus and primary visual cortex, both regions also associated with visual STM. Here we examined the relationship of visual imagery to STM and hippocampal and primary visual cortex volumes, first in a large sample of healthy people across a large age range (N = 229 behavioural data; N = 56 MRI data in older participants) and then in patients with Alzheimer's disease and Parkinson's disease (N = 19 in each group compared to 19 age-matched healthy controls). We used a variant of the "What was where?" visual object-location binding task to assess the quality of remembered information over short delays. In healthy people, no evidence of a relationship between the vividness of visual imagery and any visual STM performance parameter was found. However, there was a significant positive correlation between visual imagery and the volumes of the hippocampus and primary visual cortex. Although visual STM performance was significantly impaired in patients with Alzheimer's disease, their vividness of visual imagery scores were comparable to those of age-matched elderly controls and patients with Parkinson's disease. Despite hippocampal volumes also being reduced in Alzheimer's patients, there appeared to be no impact on their self-reported visual imagery. In conclusion, visual imagery was not significantly related to visual STM performance, either in healthy controls or Alzheimer's or Parkinson's disease but it was related to hippocampal and visual cortex volume in healthy people.Entities:
Keywords: Alzheimer's disease; Hippocampus; Parkinson's disease; Visual imagery; Working memory
Mesh:
Year: 2021 PMID: 34894605 PMCID: PMC8776564 DOI: 10.1016/j.cortex.2021.10.011
Source DB: PubMed Journal: Cortex ISSN: 0010-9452 Impact factor: 4.027
Fig. 1Task Schematic of the short-term memory task. Participants were presented with one or three fractals for a period of 1 ssec per fractal. After a blank interval of one or 4 sec, one of the fractals in the original display reappeared together with a distractor fractal. Participants first had to select the fractal which they thought had been presented previously (Identification accuracy) and drag it to where they recalled it had previously appeared (Localisation performance).
Demographics for the healthy controls (Controls in the left column also include Elderly Controls with MRIs).
| Controls (N = 229) | Elderly Controls with MRIs (N = 56) | |
|---|---|---|
| Mean Age | 57.70 (SD = 12.68, MIN = 26, MAX = 81) | 67.46 (SD = 8.04, MIN = 50, MAX = 80) |
| Mean ACE | 97.15 (SD = 2.65, MIN = 88, MAX = 100) | 97.27 (SD = 2.55, MIN = 89, MAX = 100) |
| Mean VVIQ | 61.61 (SD = 13.31, MIN = 16, MAX = 80) | 62.27 (SD = 12.41, MIN = 16, MAX = 80) |
Fig. 2Results of the short-term memory task in Healthy Controls. Increase in set size (from one to three) led to higher Localisation Error, lower Identification Accuracy and a longer Reaction Time. An increase of the delay from one to 4 sec worsened all parameters.
Fig. 3General linear model correlations of VVIQ with Identification Accuracy, Localisation Performance, Reaction Time, Misbinding and Guessing. VVIQ Scores did not correlate with any of the short-term memory task measures, rejecting our first hypothesis and suggesting an independence of visual imagery and visual STM.
Fig. 4General linear model for correlations of VVIQ and Bilateral Hippocampal Volume, Amygdala Volume, Volume of the Primary Motor Cortex, of the Primary Visual Cortex and of the Fusiform Gyrus. Vividness of Visual Imagery Questionnaire (VVIQ) Scores positively correlated with the volume of the Hippocampus and the Primary Visual Cortex but not with the volume of the Amygdala or the Primary Motor Cortex controls, suggesting an involvement of these two areas in visual imagery and confirming our second hypothesis. There was, however, no correlation of Fusiform gyrus volume and VVIQ.
Fig. 5General linear model follow-up for correlations of VVIQ and Bilateral CA1, CA3, CA4 and Granule Cell (GC) and Molecular Layer (ML) of the Dentate Gyrus (DG). The follow-up analysis revealed that visual imagery was in particular correlated with the four subfields presented in the graph.
Demographics for healthy controls versus Parkinson's disease.
| Elderly controls | Alzheimer's disease patients | Parkinson's disease patients | |
|---|---|---|---|
| Mean Age in years | 70.37 (SD = 8.32, MIN = 54, MAX = 80) | 71.11 (SD = 9.99, MIN = 53, MAX = 89) | 69.21 (SD = 7.34, MIN = 52, MAX = 80) |
| Mean ACE | 96.58 (SD = 2.95, MIN = 89, MAX = 100) | 74.58∗ (SD = 13.11, MIN = 45, MAX = 96) | 95.47 (SD = 2.37, MIN = 92, MAX = 99) |
| Mean VVIQ | 61.16 (SD = 9.21, MIN = 46, MAX = 76) | 63.26 (SD = 11.25, MIN = 36, MAX = 80) | 69.32∗ (SD = 10.45, MIN = 45, MAX = 80) |
| Mean Bilateral Hippocampal Volume (mm3) | 7318.74 (SD = 719.68, MIN = 5961.90, MAX = 8220.91) | 6017.07∗ (SD = 733.82, MIN = 4819.91, MAX = 7727.97) | 7330.87 (SD = 785.24, MIN = 6040.85, MAX = 8656.33) |
| Mean Bilateral Amygdala Volume (mm3) | 2525.51 (SD = 433.75, MIN = 1796.43, MAX = 3489.47) | 2172.32∗ (SD = 316.71, MIN = 1729.34, MAX = 2816.08) | 2724.49 (SD = 363.41, MIN = 1914.76, MAX = 3243.03) |
| Mean Bilateral Primary Visual Cortex Volume (mm3) | 13971.44 (SD = 2750.19, MIN = 10876.31, MAX = 20605.82) | 14002.82 (SD = 2072.93, MIN = 10555.07, MAX = 16816.65) | 13706.53 (SD = 1978.12, MIN = 9871.03, MAX = 16627.85) |
| Mean Bilateral Primary Motor Cortex Volume (mm3) | 23306.06 (SD = 1932.36, MIN = 19188.60, MAX = 28152.79) | 23796.44 (SD = 2451.65, MIN = 18934.01, MAX = 28120.25) | 23268.03 (SD = 2700.09, MIN = 14176.87, MAX = 27185.24) |
| Mean Bilateral Fusiform Cortex Volume (mm3) | 18959.33 (SD = 1931.04, MIN = 14579.38, MAX = 21900.53) | 17294.94∗ (SD = 1807.01, MIN = 13874.18, MAX = 20702.69) | 18653.62 (SD = 1843.25, MIN = 14493.03, MAX = 22222.333) |
| Mean Bilateral CA1 Volume (mm3) | 1259.72 (SD = 121.30, MIN = 1037.25, MAX = 1428.60) | 1053.54∗ (SD = 136.94, MIN = 823.12, MAX = 1289.59) | 1298.42 (SD = 144.72, MIN = 999.25, MAX = 1521.57) |
| Mean Bilateral CA3 Volume (mm3) | 429.15, (SD = 39.95, MIN = 368.96, MAX = 492.79) | 318.52∗ (SD = 57.81, MIN = 238.58, MAX = 455.30) | 422.29 (SD = 43.95, MIN = 337.26, MAX = 489.78) |
| Mean Bilateral CA4 Volume (mm3) | 500.07, (SD = 38.95, MIN = 420.95, MAX = 565.76) | 419.10∗ (SD = 41.25, MIN = 352.26, MAX = 508.70) | 504.87 (SD = 42.49, MIN = 421.41, MAX = 569.43) |
| Mean Bilateral GC-ML-DG Volume (mm3) | 570.31 (SD = 48.74, MIN = 471.83, MAX = 653.23) | 483.15∗ (SD = 48.24, MIN = 408.24, MAX = 589.02) | 583.62 (SD = 47.39, MIN = 481.96, MAX = 662.63) |
Note: Asterisks mark significant differences between patients and controls as defined by independent samples t-tests.
Fig. 6Short-term-memory task results in Alzheimer's and Parkinson's disease compared to controls. Healthy Controls identified the target faster and more often correctly than Alzheimer's Disease Patients, placed the target closer to its original location and guessed and misbound less. Parkinson's patients performed at the same level as controls.
Fig. 7ACE, Age and VVIQ scores and hippocampal volumes in Alzheimer's and Parkinson's disease. In comparison to approximately age-matched controls, there was no significant decrease of VVIQ Scores in Alzheimer's Disease patients (A) despite a decrease of ACE and hippocampal volumes (B). Hippocampal volumes are depicted as cumulative distribution function showing that distributions for Parkinson's disease and Controls are very similar but there is a general shift to smaller volumes in Alzheimer's disease.